Analyst Ratings for Redhill Biopharma (RDHL) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/31/2021 | Cantor Fitzgerald » Updated 11/22/2022 |
Brandon Folkes | New Coverage | Overweight (N/A) |
1.00 (11.00) |
8.59 (0.42) |
-95.11% | Details |
| 5/28/2021 | WBB Securities | Steve Brozak | Downgrade | Buy (Strong Buy) |
N/A (N/A) |
7.14 (0.42) |
-94.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
